Mortality trends from sepsis and gastrointestinal cancer among United States adults: A CDC WONDER–based analysis.

E Ehsanullah Alokozay (Faculty of Medicine, Kandahar University, Kandahar, Afghanistan) M Mohamed Fawzi Hemida A Alyaa Ahmed Ibrahim A Amro Ali (Community Regional Medical Center, Fresno, CA) F FNU Sahil (LUMHS Jamshoro, Jamshoro, Pakistan) N Nikil Kumar (Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, Sindh, Pakistan) H Hasnain Wajeeh Saqib (Islamic International Medical, Rawalpindi, Pakistan) D Dheeraj Kumar M Mahmoud Tablawy (Faculty of Medicine Alazhar University, Cairo, Egypt) A Abdelrhman H. Mohamed (Faculty of Medicine, Luxor University, Luxor, Egypt) A Abdelrahman Aly Mohamed (Faculty of Medicine, Helwan University, Cairo, Egypt) A Ahmed Sami Fdle (Egyptian Ministry of health, Cairo, Egypt) M Mina Nageh Hemaya (Tbilisi State University, Tbilisi, Georgia) M Mohamed Olama (Benha University Hospital, Banha, Egypt) A Abdelrahman Gouda (Department of Radiation Oncology, Shefaa Al-Orman Hospital, Luxor, Egypt) A Ahmed Abdelaziz O Omar Muhamed Kamel Othman (Sohag University Hospital, Naser City, Egypt)

Abstract

e15673 Background: Sepsis is a major contributor to mortality among patients with gastrointestinal (GI) cancers. Population-level related mortality trends and disparities among the United States population remain underexplored. This study evaluates national trends and demographic differences in GI cancer-related sepsis mortality in the United States. Methods: We analyzed mortality data from the CDC WONDER Multiple Cause-of-Death dataset from 1999 to 2023. We calculated age-adjusted mortality rates (AAMRs) per 100,000, stratified by age, sex, race/ethnicity, states, and urban-rural classification. Joinpoint regression was used to estimate average annual percent change (AAPC) and annual percent change (APC) with 95% confidence intervals (CIs). Statistical significance was defined as p<0.05. Results: Between 1999 and 2023, 171,744 deaths occurred from GI cancer-related sepsis. The AAMR per 100,000 raised from 2.98 in 1999 to 3.81 in 2023 (AAPC: 1.26%; 95% CI: 0.97-1.55; p<0.001). Males showed a higher mean AAMR of 3.91 versus 2.28 in females. Age analysis showed the highest mortality rate in the age group of more than 65 years (10.55). By race, non-Hispanic (NH) Black or African American individuals had the highest AAMR (4.90), followed by NH Asian or Pacific Islander (3.48), Hispanic or Latino (3.46), NH American Indian or Alaska Native (3.04), and NH White (2.75). Urbanization disparities revealed higher AAMRs in Metropolitan (2.95) than Non-Metropolitan areas (2.70). The Northeast region had the highest AAMR (3.18), followed by the West (3.17), the South (3.01), and the Midwest (2.62). In state-wise analysis, the District of Columbia had the highest AAMR (6.12), while the state of Maine had the lowest (0.94). Conclusions: GI cancer-related sepsis mortality in the United States has increased significantly over the past two decades, with significant disparities by sex, race/ethnicity, geography, and urbanization. These findings underscore the need for equity-focused interventions and enhanced clinical recognition of demographic-based risk factors, which could lead to a quicker estimation of the prognosis and improved sepsis management in cancer care. Deaths and age-adjusted mortality rates (AAMRs) per 100,000 for trends related to sepsis and gastrointestinal cancer mortality among United States adults between 1999 and 2023. Variable Deaths (n) AAMR (95% CI) Overall 171,744 3.00(2.93-3.07) SEX Male 99,411 3.91(3.78-4.03) Female 72,333 2.28(2.19-2.36) RACE/ETHNICITY NH American Indians 1313 3.04(2.20-4.10) NH Asians 8200 3.48(3.07-3.89) NH Blacks 27747 4.90(4.60-5.20) NH White 130374 2.75(2.67-2.82) Hispanics 17114 3.46(3.17-3.74)

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (17)

E

Ehsanullah Alokozay

Faculty of Medicine, Kandahar University, Kandahar, Afghanistan

M

Mohamed Fawzi Hemida

A

Alyaa Ahmed Ibrahim

A

Amro Ali

Community Regional Medical Center, Fresno, CA

F

FNU Sahil

LUMHS Jamshoro, Jamshoro, Pakistan

N

Nikil Kumar

Liaquat University of Medical and Health Sciences (LUMHS), Jamshoro, Sindh, Pakistan

H

Hasnain Wajeeh Saqib

Islamic International Medical, Rawalpindi, Pakistan

D

Dheeraj Kumar

M

Mahmoud Tablawy

Faculty of Medicine Alazhar University, Cairo, Egypt

A

Abdelrhman H. Mohamed

Faculty of Medicine, Luxor University, Luxor, Egypt

A

Abdelrahman Aly Mohamed

Faculty of Medicine, Helwan University, Cairo, Egypt

A

Ahmed Sami Fdle

Egyptian Ministry of health, Cairo, Egypt

M

Mina Nageh Hemaya

Tbilisi State University, Tbilisi, Georgia

M

Mohamed Olama

Benha University Hospital, Banha, Egypt

A

Abdelrahman Gouda

Department of Radiation Oncology, Shefaa Al-Orman Hospital, Luxor, Egypt

A

Ahmed Abdelaziz

O

Omar Muhamed Kamel Othman

Sohag University Hospital, Naser City, Egypt